Immunocore Holdings (IMCR) Equity Ratio (2022 - 2025)
Historic Equity Ratio for Immunocore Holdings (IMCR) over the last 4 years, with Q3 2025 value amounting to 0.36.
- Immunocore Holdings' Equity Ratio rose 325.87% to 0.36 in Q3 2025 from the same period last year, while for Sep 2025 it was 0.36, marking a year-over-year increase of 325.87%. This contributed to the annual value of 0.36 for FY2024, which is 4216.51% down from last year.
- Per Immunocore Holdings' latest filing, its Equity Ratio stood at 0.36 for Q3 2025, which was up 325.87% from 0.36 recorded in Q2 2025.
- In the past 5 years, Immunocore Holdings' Equity Ratio ranged from a high of 0.64 in Q4 2022 and a low of 0.35 during Q3 2024
- Moreover, its 4-year median value for Equity Ratio was 0.36 (2025), whereas its average is 0.42.
- As far as peak fluctuations go, Immunocore Holdings' Equity Ratio tumbled by 4216.51% in 2024, and later surged by 325.87% in 2025.
- Over the past 4 years, Immunocore Holdings' Equity Ratio (Quarter) stood at 0.64 in 2022, then decreased by 3.97% to 0.62 in 2023, then plummeted by 42.17% to 0.36 in 2024, then rose by 0.66% to 0.36 in 2025.
- Its last three reported values are 0.36 in Q3 2025, 0.36 for Q2 2025, and 0.37 during Q1 2025.